WAUKEGAN, Ill.--(BUSINESS WIRE)--NEOPHARM, Inc. (Nasdaq:NEOL - News) today announced a second quarter 2006 net loss of approximately $9.8 million, or $0.35 per basic and diluted share, and a first half 2006 net loss of approximately $17.5 million, or $0.63 per basic and diluted share.
